Pain · 2009 · 221 citations · 28 references
MedicineImmunologyPharmacologyInflammationMolecular PharmacologyPain MedicineAnalgesiaAnti-inflammatory PharmacologyInflammation PharmacologyInflammatory PainInflammatory ProcessesPain MechanismsInflammation-pain CouplingInflammatory Pain ModulationMechanical HyperalgesiaPersistent Inflammation SyndromeReceptor-mediated AnalgesiaTransient Receptor Potential Channel PharmacologyTransient Receptor Potential Channels
This study investigated the role of TRPA1 in the development and maintenance of mechanical and cold hyperalgesia in persistent inflammation induced by Complete Freund's Adjuvant (CFA) in mice. The intraplantar (i.pl.) injection of CFA induced a long lasting (28 days) hyperalgesia for both mechanical and thermal (cold) stimuli. The intraperitoneal (i.p., 30-300 mg/kg), intraplantar (i.pl., 100 microg/site) or intrathecal (i.t., 10 microg/site) injection of the TRPA1 selective antagonist HC-030031 significantly reduced the mechanical hyperalgesia evaluated by the von Frey hair test. The effect of HC-030031 was evidenced on the day after CFA injection and was kept throughout the test. However, the intracerebroventricular (i.c.v., 10 microg/site) injection of HC-030031 did not interfere with CFA-induced hyperalgesia. Treatment with HC-030031 (300 mg/kg, i.p.) completely inhibited the noxious cold hyperalgesia induced by tetrafluoroethane in mice that received CFA. The pre-treatment with the TRPA1 oligonucleotide antisense (AS-ODN, i.t.) consistently prevented both mechanical and cold hyperalgesia. Interestingly, both TRPA1 protein expression and mRNA were over-expressed in spinal cord and dorsal root ganglia (DRG) of mice treated with CFA, an effect that was fully prevented by the pre-treatment with the TRPA1 antagonist HC-030031. Collectively, the present results showed that TRPA1 present at either peripheral or spinal sites play a relevant role in the development and maintenance of both mechanical and cold hyperalgesia during CFA-induced inflammation. Thus, TRPA1 selective antagonists represent promising candidates to treat hyperalgesia in persistent inflammatory states.
28
Ethical guidelines for investigations of experimental pain in conscious animals
M. Zimmermann · Pain · 1983 · 7.8K citations
ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, Is Activated by Cold Temperatures
Gina M. Story, Andrea Peier, Alison J. Reeve et al. · Cell · 2003 · 2.5K citations · Full text
Intrathecal morphine in mice: A new technique
Janice L.K. Hylden, George L. Wilcox · European Journal of Pharmacology · 1980 · 1.9K citations
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents
Diana M. Bautista, S.E. Jordt, Tetsuro Nikai et al. · Cell · 2006 · 1.9K citations · Full text
Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1
Sven‐Eric Jordt, Diana M. Bautista, Huai-hu Chuang et al. · Nature · 2004 · 1.9K citations